Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
BD to Present at Investor Healthcare Conferences
04:15pm, Wednesday, 23'rd Aug 2023
FRANKLIN LAKES, N.J. , Aug. 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following
BD (BDX) Q3 Earnings Surpass Estimates, Margins Contract
02:15pm, Thursday, 03'rd Aug 2023
BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal third quarter.
Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11:16am, Thursday, 03'rd Aug 2023
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall
Becton Dickinson beats quarterly profit estimates on strong medical device sales
08:00am, Thursday, 03'rd Aug 2023
Becton Dickinson beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its drug delivery devices and surgical equipment.
BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?
02:45pm, Friday, 28'th Jul 2023
Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited Q3 sales.
7 Stocks Getting a Huge Vote of Confidence From Wall Street Analysts
06:00am, Thursday, 27'th Jul 2023
While discrediting the acumen of experts seems to be a popular exercise on the Internet, investors can potentially gain handsomely from top analyst stocks. Of course, you'll find some research on this
Why Becton Dickinson (BDX) is Poised to Beat Earnings Estimates Again
01:55pm, Wednesday, 26'th Jul 2023
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Becton Dickinson (BDX) Surges 5.7%: Is This an Indication of Further Gains?
09:22am, Tuesday, 25'th Jul 2023
Becton Dickinson (BDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more str
S&P 500 Gains and Losses Today: Oil Industry Stocks Surge as Oil Prices Rise
05:25pm, Monday, 24'th Jul 2023
U.S. equities gained after better-than-expected second quarter earnings reports, with the S&P 500 rising 0.4% on Monday, July 24, 2023.
Becton Dickinson Shares Jump After FDA Decision on Its Infusion System
04:30pm, Monday, 24'th Jul 2023
Shares of Becton Dickinson rose to their highest level since 2020 after the FDA gave 501(k) clearance to Becton Dickinson's updated BD Alaris Infusion System.
Markets Higher at Midday as Rising Crude Prices Boost Oil Industry Stocks
01:20pm, Monday, 24'th Jul 2023
The earnings-fueled stock market rally continued at midday on Monday, July 24, 2023.
BD (BDX) Receives FDA Nod to Address Critical Infusion Needs
01:05pm, Monday, 24'th Jul 2023
The latest regulatory clearance for BD's (BDX) Alaris Infusion System is expected to improve healthcare system efficiency via better care coordination and utilization of actionable information.
Becton Dickinson shares hit record high after US FDA clears return of drug infusion system
12:52pm, Monday, 24'th Jul 2023
Shares of Becton Dickinson hit an all-time high on Monday and were last up 6.1% after the medical device maker received U.S. Food and Drug Administration clearance late on Friday for the market return
Why Shares of Becton, Dickinson Rose Monday
12:51pm, Monday, 24'th Jul 2023
The company filed a 501(k) resubmission for its new BD Alaris Infusion System two years ago. The company said it will begin immediately distributing the new Alaris Infusion System, and will remediate
BDX or ALGN: Which Is the Better Value Stock Right Now?
01:08pm, Friday, 07'th Jul 2023
Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Align Technology (ALGN). But which of these two stocks is more attractive to value investor
